Diagnostic Imaging
Spotlight
RSNA 2021 CoverageCTImage IQ Quiz
Topics
View MoreMRICTUltrasoundMammographyX-RayFacility ManagementView More
Neurology CTOncology Ultrasound
News
All NewsBlogs
Media
Around the Practice Between the LinesImage IQMedical World NewsPodcastsVideos
Conferences
Conference CoverageConference Listing
DI Executive
Resources
CME/CEE-booksEducationPartnersSponsored
Subscribe
eNewsletterPrint Subscription

  • Advertise
  • Contact Us
  • Editorial
  • Editorial Board
  • Do Not Sell My Personal Information
  • Privacy
  • Terms and Conditions
  • MJHLS Brand Logo

© 2022 MJH Life Sciences and Diagnostic Imaging. All rights reserved.

Spotlight
  • RSNA 2021 Coverage
  • CT
  • Image IQ Quiz
TopicsSee All >
  • MRI
  • CT
  • Ultrasound
  • Mammography
  • X-Ray
  • Facility Management
  • View More
Neurology CTSee All >
    Oncology UltrasoundSee All >
      • Advertise
      • Contact Us
      • Editorial
      • Editorial Board
      • Do Not Sell My Personal Information
      • Privacy
      • Terms and Conditions
      • MJHLS Brand Logo

      © 2022 MJH Life Sciences™ and Diagnostic Imaging. All rights reserved.

      Between the Lines


      18F-Fluciclovine Versus 68Ga-PSMA-11 Imaging for Prostate Cancer Biochemical Recurrence

      December 23rd 2021

      Steven Finkelstein, MD, DABR, FACRO, and Louis J. Mazzarelli, MD, react to the article, “A Prospective Head-to-Head Comparison of 18F-Fluciclovine With 68Ga-PSMA-11 in Biochemical Recurrence of Prostate Cancer in PET/CT,” by Pernthaler B, et al.